Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
11458 | 913 | 25.1 | 51% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
335 | 17284 | BLADDER CANCER//CYSTECTOMY//URINARY DIVERSION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | COMPUTER BASED CLASSIFICATION | Author keyword | 4 | 75% | 0% | 3 |
2 | BLADDER WASHING | Author keyword | 2 | 33% | 1% | 6 |
3 | TRANSITIONAL CELL BLADDER CANCER | Author keyword | 2 | 38% | 1% | 5 |
4 | URODIAGNOST GRP | Address | 2 | 67% | 0% | 2 |
5 | PAPILLARY STATUS | Author keyword | 2 | 50% | 0% | 3 |
6 | 2C DEVIATION INDEX | Author keyword | 1 | 100% | 0% | 2 |
7 | 5C EXCEEDING RATE | Author keyword | 1 | 100% | 0% | 2 |
8 | BLOOD GROUP ISOANTIGENS | Author keyword | 1 | 100% | 0% | 2 |
9 | HUMAN UROTHELIAL CELLS | Author keyword | 1 | 50% | 0% | 2 |
10 | M V INDEX | Author keyword | 1 | 50% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | COMPUTER BASED CLASSIFICATION | 4 | 75% | 0% | 3 | Search COMPUTER+BASED+CLASSIFICATION | Search COMPUTER+BASED+CLASSIFICATION |
2 | BLADDER WASHING | 2 | 33% | 1% | 6 | Search BLADDER+WASHING | Search BLADDER+WASHING |
3 | TRANSITIONAL CELL BLADDER CANCER | 2 | 38% | 1% | 5 | Search TRANSITIONAL+CELL+BLADDER+CANCER | Search TRANSITIONAL+CELL+BLADDER+CANCER |
4 | PAPILLARY STATUS | 2 | 50% | 0% | 3 | Search PAPILLARY+STATUS | Search PAPILLARY+STATUS |
5 | 2C DEVIATION INDEX | 1 | 100% | 0% | 2 | Search 2C+DEVIATION+INDEX | Search 2C+DEVIATION+INDEX |
6 | 5C EXCEEDING RATE | 1 | 100% | 0% | 2 | Search 5C+EXCEEDING+RATE | Search 5C+EXCEEDING+RATE |
7 | BLOOD GROUP ISOANTIGENS | 1 | 100% | 0% | 2 | Search BLOOD+GROUP+ISOANTIGENS | Search BLOOD+GROUP+ISOANTIGENS |
8 | HUMAN UROTHELIAL CELLS | 1 | 50% | 0% | 2 | Search HUMAN+UROTHELIAL+CELLS | Search HUMAN+UROTHELIAL+CELLS |
9 | M V INDEX | 1 | 50% | 0% | 2 | Search M+V+INDEX | Search M+V+INDEX |
10 | PLOIDIES | 1 | 10% | 1% | 12 | Search PLOIDIES | Search PLOIDIES |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLASSIC PROGNOSTICATORS | 19 | 71% | 2% | 15 |
2 | HISTOQUANTITATIVE METHODS | 12 | 86% | 1% | 6 |
3 | ACID FLOW CYTOMETRY | 6 | 53% | 1% | 8 |
4 | NUCLEAR MORPHOMETRIC VARIABLES | 4 | 67% | 0% | 4 |
5 | CORRECTED MITOTIC INDEX | 4 | 38% | 1% | 9 |
6 | BLOOD GROUP ABH | 2 | 67% | 0% | 2 |
7 | DEPARAFFINIZED NUCLEI | 2 | 50% | 0% | 3 |
8 | M V INDEX | 2 | 40% | 0% | 4 |
9 | MORPHOMETRIC VARIABLES | 2 | 43% | 0% | 3 |
10 | IMMUNOCYTOLOGY | 1 | 21% | 1% | 6 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
DNA image cytometry in bladder cancer: State of the art | 2008 | 3 | 65 | 51% |
QUANTITATIVE LIGHT-MICROSCOPY IN UROLOGICAL ONCOLOGY | 1992 | 33 | 132 | 27% |
RECURRENT OR AGGRESSIVE BLADDER-CANCER - INDICATIONS FOR ADJUVANT INTRAVESICAL THERAPY | 1992 | 23 | 77 | 32% |
REVIEW OF CYTOMETRIC METHODS IN THE ASSESSMENT OF PROGNOSIS IN TRANSITIONAL CELL BLADDER-CANCER | 1992 | 10 | 56 | 52% |
THE SIGNIFICANCE OF IMMUNE CYTOLOGICAL DIAGNOSTICS FOR BLADDER-CARCINOMA | 1991 | 1 | 7 | 100% |
Use of monoclonal antibodies for the diagnosis and treatment of bladder cancer | 1999 | 6 | 43 | 26% |
THE USE OF MONOCLONAL-ANTIBODIES FOR THE DIAGNOSIS AND THERAPY OF BLADDER-CANCER | 1993 | 8 | 49 | 39% |
BLOOD-GROUP ANTIGENS AND BLADDER-CARCINOMA - A PERSPECTIVE | 1982 | 37 | 9 | 89% |
Recent aspects in the diagnosis and prognosis of bladder cancer | 1998 | 1 | 56 | 23% |
PRACTICAL UTILITY OF SPECIFIC RED-CELL ADHERENCE TEST IN BLADDER-CANCER | 1981 | 44 | 3 | 100% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | URODIAGNOST GRP | 2 | 67% | 0.2% | 2 |
2 | IMAGE ANAL CELLULAR PATHOL | 1 | 50% | 0.1% | 1 |
3 | BIOSTAT UROL | 0 | 17% | 0.1% | 1 |
4 | NIHR BIOMED UNITQUEENS MED | 0 | 17% | 0.1% | 1 |
5 | ONKOL CHEM | 0 | 17% | 0.1% | 1 |
6 | RUDOLF VIRCHOW MED | 0 | 14% | 0.1% | 1 |
7 | ICBA | 0 | 11% | 0.1% | 1 |
8 | UROPATHOL | 0 | 10% | 0.1% | 1 |
9 | BIOENGN BIOMATH | 0 | 100% | 0.1% | 1 |
10 | BIOMED INFORMAT PROC METHODS | 0 | 100% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000212667 | NMP22//UROVYSION//URINE CYTOLOGY |
2 | 0.0000138154 | S PHASE FRACTION//ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY//DNA PLOIDY |
3 | 0.0000129197 | FGFR3//GENES P53//DBCCR1 |
4 | 0.0000121538 | GIRENTUXIMAB//G250//MONOCLONAL ANTIBODY CG250 |
5 | 0.0000117670 | SUPERFICIAL BLADDER CANCER//NON MUSCLE INVASIVE BLADDER CANCER//BACILLUS CALMETTE GUERIN |
6 | 0.0000096741 | MALIGNANCY ASSOCIATED CHANGES//NUCLEAR TEXTURE ANALYSIS//KARYOMETRY |
7 | 0.0000091851 | FEULGEN STAINING//MORPHONUCLEAR CHARACTERISTICS//DIGITAL CELL IMAGE ANALYSIS |
8 | 0.0000063337 | FUCOSYLTRANSFERASE//LEWIS Y ANTIGEN//FUT2 |
9 | 0.0000050961 | TN ANTIGEN//SIALYL TN//SIALYL TN ANTIGEN |
10 | 0.0000049320 | ORTHO PHENYLPHENOL//XANTHINE OXIDOREDUCTASE INHIBITOR//EVALUAT ENVIRONM IMPACT HUMAN HLTH TOXICAM |